Cover Image

Thomson-Laboratory/Dynamic_JAK-STAT_IFN: JAK-STAT_IFN_v1.0.0

Fuente: Zenodo

Saved in:

Bibliographic Details
Main Author:	yshs01
Format:	Recurso digital
Published:	Zenodo 2026
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

ACSM3 Suppresses Ovarian Cancer Progression by Inactivating the IFN‐γ/JAK/STAT3 Signaling Pathway
by: Juan Wang, et al.
Published: (2025)

AIM2 inflammasome regulated by the IFN‐γ/JAK2/STAT1 pathway promotes activation and pyroptosis of monocytes in Coronary Artery Disease
by: Yue Zhao, et al.
Published: (2024)

Activated Peripheral CD8 + T Lymphocytes Inhibit the Proliferation of Hippocampal Neural Stem Cells via the IFN‐γ/JAK/STAT Signaling Pathway
by: Xiaowei Li, et al.
Published: (2025)

Pseudorabies Virus UL41 Hijacks IFN Response via JAK/STAT Pathway While Cellular TRIM21 Blocks it Through K48 Ubiquitination
by: Xue Li, et al.
Published: (2025)

Expression of JAK/STAT signalling in bullous pemphigoid
by: Laxmi Iyengar, et al.
Published: (2024)

Microglial priming by IFN‐γ involves STAT1‐mediated activation of the NLRP3 inflammasome
by: Haili He, et al.
Published: (2024)

The Involvement of IFN ‐γ/ STAT 1 Signaling in the Regulation of Ferroptosis in Cerebral Ischemia/Reperfusion Injury
by: Jiachen Li, et al.
Published: (2025)

JAK/STAT defects and immune dysregulation, and guiding therapeutic choices
by: Natalia S. Chaimowitz, et al.
Published: (2024)

JAK/STAT inhibitors mitigate sepsis‐associated cerebral and cognitive injury
by: Mohini Singh Bhadauriya, et al.
Published: (2025)

01QJ10/QAM: v1.0.0 – Initial Release of ACM (Unstable)
by: 01QJ10
Published: (2025)

Ruxolitinib Suppresses Interferon‐γ‐Induced JAK/STAT Activation in Oral Keratinocytes
by: Kim N. Stolte, et al.
Published: (2026)

Potential Modulatory Effects of Hesperidin on the JAK/STAT Pathway in Mesangial Proliferative Glomerulonephritis
by: Yingchun Tang, et al.
Published: (2025)

Dual‐Barb Microneedle with JAK/STAT Inhibitor‐Loaded Nanovesicles Encapsulation for Tendinopathy
by: Minhao Chen, et al.
Published: (2024)

169 | PHOSPHO‐STAT3 EXPRESSION AND JAK/STAT PATHWAY ACTIVATION ACROSS GENETIC SUBTYPES OF DIFFUSE LARGE B‐CELL LYMPHOMA
by: A. A. Pomares, et al.
Published: (2025)

The Evolution of IL6-IL6R-JAK-STAT Signaling Pathway in Metazoan.
by: Yu, Hong, et al.
Published: (2026)

ACSL3 Promotes Hepatocellular Carcinoma Tumorigenesis and Correlates With JAK – STAT3 Signaling
by: Melika Amelimojarad, et al.
Published: (2026)

Erratum to “The Role of Natural Products as Inhibitors of JAK/STAT Signaling Pathways in Glioblastoma Treatment”
Published: (2025)

gl0bal01/discord-amazon-rekognition: v1.0.0
by: gl0bal01 龴ↀ◡ↀ龴
Published: (2025)

Dupilumab‐Induced Psoriasis‐Like Eruption With JAK1 ‐ STAT3 Activation Successfully Treated With Upadacitinib
by: Yoshihiro Goto, et al.
Published: (2025)

177 | Spatial Transcriptomic Analysis of Treatment‐Naïve Inflammatory Myopathy Muscle—The JAK/STAT Story
Published: (2026)

Targeting JAK–STAT signaling for autoimmune diseases: current understanding, clinical advances, and emerging directions
by: Zhimin Wu, et al.
Published: (2026)

Cytokine receptor and JAK/STAT pathway mutations in acute myeloid leukemia: Prevalence and clinical impact
by: Moath Albliwi, et al.
Published: (2026)

FCGBP Promotes Glioma Growth by Regulating JAK2 / STAT3 /c‐Myc Pathway
by: Jin Zheng, et al.
Published: (2026)

Large‐scale meta‐analysis of infection risk with JAK – STAT inhibitors in 29,000 patients
by: Máté Krebs, et al.
Published: (2026)

IL‐27: A Double‐Edged Sword in Immune Regulation via JAK‐STAT Orchestration
by: Xiangqi Zhang, et al.
Published: (2026)

KIAA0040 enhances glioma growth by controlling the JAK2/STAT3 signalling pathway
by: Jie He, et al.
Published: (2024)

Proteomic Analysis Reveals Oxidative Phosphorylation and JAK ‐ STAT Pathways Mediated Pathogenesis of Pemphigus Vulgaris
by: Yuqi Cheng, et al.
Published: (2024)

Targeting glypicans through EGFR and JAK/STAT signaling axes drives breast cancer progression
by: Paraskevi Ioannou, et al.
Published: (2024)

Innovative Multitarget Organoselenium Hybrids With Apoptotic and Anti‐Inflammatory Properties Acting as JAK1/STAT3 Suppressors
by: Saad Shaaban, et al.
Published: (2025)

Novel Use of a Topical JAK / STAT Inhibitor in the Management of Refractory Erythromelalgia: A Case Report
by: Alexandra Gershman, et al.
Published: (2026)

Microalgae-Based Fucoxanthin Attenuates Rheumatoid Arthritis by Targeting the JAK-STAT Signaling Pathway and Gut Microbiota.
by: Xu, Hui-Ying, et al.
Published: (2025)

Efficient Generation of Megakaryocyte Progenitors and Platelets From HSPCs via JAK2/STAT3 Signaling
by: Huicong Liu, et al.
Published: (2025)

Langat virus inhibits the gp130/JAK/STAT signaling by reducing the gp130 protein level
by: Shaoli Lin, et al.
Published: (2024)

NIBAN2 Stimulates Glioma Growth by Regulating the JAK2/STAT3/c‐Myc Pathway
by: Zhi‐ming Chen, et al.
Published: (2025)

DRAM1‐defined autophagy‐JAK‐STAT‐Tregs axis drives immunosuppression and predicts immunotherapy response in pan‐cancer
by: Jinchun Wu, et al.
Published: (2026)

LMOD1 Exerts a Tumor‐Suppressive Role in Breast Cancer by Restraining the JAK2/STAT3 Pathway
by: Xiansong Fang, et al.
Published: (2024)

DHCR7 drives AML development through the IL6 / JAK2 / STAT3 signalling pathway
by: Xu Dai, et al.
Published: (2026)

JPH3 Facilitates Cisplatin Resistance in Anaplastic Thyroid Cancer via Activation of the JAK – STAT Signaling Pathway
by: Xiuyan Wang, et al.
Published: (2026)

JAK–STAT inhibitory effect of IN‐115314, a novel small molecule inhibitor, and pharmacokinetic/pharmacodynamic study in canine
by: Jae‐Hun Ahn, et al.
Published: (2025)

TIMP‐2 Modulates 5‐Fu Resistance in Colorectal Cancer Through Regulating JAK–STAT Signalling Pathway
by: Chuchu Xu, et al.
Published: (2025)